|
|
|
Insider
Information: |
Link William J Phd |
Relationship: |
|
City: |
Santa Ana |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
858,870 |
|
Indirect Shares
|
8,818,270 |
|
|
Direct
Value |
$6,361,044 |
|
|
Indirect Value
|
$51,085,513 |
|
|
Total
Shares |
9,677,140 |
|
|
Total
Value |
$57,446,557 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-26.5%
|
-6.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
Director |
2020-05-08 |
11,349 |
2020-05-08 |
10,772 |
Premium* |
|
Inogen Inc |
INGN |
Director, 10% Owner |
|
0 |
2014-02-20 |
3,695,816 |
Premium* |
|
Vivani Medical, Inc |
VANI |
Director |
2018-06-01 |
115,186 |
2017-06-01 |
4,492,975 |
Premium* |
|
Glaukos Corp |
GKOS |
Director |
2021-06-03 |
17,821 |
2021-06-03 |
40,479 |
Premium* |
|
Oyster Point Pharma, Inc. |
OYST |
Director |
2022-01-05 |
10,066 |
2022-01-05 |
447,088 |
Premium* |
|
Lensar, Inc. |
LNSR |
|
2024-05-07 |
543,267 |
|
0 |
Premium* |
|
Tarsus Pharmaceuticals, Inc. |
TARS |
Director |
2023-06-16 |
136,632 |
2023-05-11 |
109,892 |
Premium* |
|
Rxsight, Inc. |
RXST |
|
2024-02-01 |
24,549 |
2024-02-01 |
21,248 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GKOS |
Glaukos Corp |
Director |
|
2016-06-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(128,758) |
0 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2020-12-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(955,392) |
0 |
0 |
- |
|
TARS |
Tarsus Pharmaceuticals, I... |
Director |
|
2023-05-11 |
4 |
AS |
$0.00 |
$0 |
I/I |
(215,576) |
0 |
0 |
- |
|
RXST |
Rxsight, Inc. |
Director |
|
2023-05-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(258,390) |
0 |
0 |
- |
|
RXST |
Rxsight, Inc. |
Director |
|
2023-08-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(694,124) |
0 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2021-03-26 |
4 |
A |
$0.00 |
$0 |
I/I |
10,933 |
631 |
0 |
- |
|
GKOS |
Glaukos Corp |
Director |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
129,747 |
989 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2021-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
10,944 |
1,273 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2021-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
6,838 |
1,673 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2022-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
6,839 |
2,074 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
Director |
|
2009-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,178 |
3,178 |
0 |
- |
|
TARS |
Tarsus Pharmaceuticals, I... |
Director |
|
2021-11-11 |
4 |
A |
$0.00 |
$0 |
I/I |
4,348 |
4,348 |
0 |
- |
|
GKOS |
Glaukos Corp |
|
|
2018-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,633 |
4,633 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
Director |
|
2019-08-21 |
4 |
S |
$222.02 |
$366,328 |
I/I |
(1,650) |
4,722 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2021-10-18 |
4 |
AS |
$14.63 |
$8,160,736 |
I/I |
(550,000) |
4,987 |
0 |
% |
|
VANI |
Vivani Medical, Inc |
Director |
|
2015-06-01 |
4 |
A |
$12.32 |
$66,996 |
D/D |
5,438 |
5,438 |
0 |
- |
|
RXST |
Rxsight, Inc. |
Director |
|
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,859 |
5,859 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
Director |
|
2018-11-19 |
4 |
S |
$149.88 |
$2,035,568 |
I/I |
(13,578) |
6,050 |
0 |
- |
|
OYST |
Oyster Point Pharma, Inc. |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
6,600 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
Director |
|
2009-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
6,644 |
0 |
- |
|
GKOS |
Glaukos Corp |
|
|
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,140 |
6,773 |
0 |
- |
|
TARS |
Tarsus Pharmaceuticals, I... |
Director |
|
2022-08-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,749 |
8,097 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
Director |
|
2010-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,186 |
8,830 |
0 |
- |
|
GKOS |
Glaukos Corp |
Director |
|
2019-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,653 |
9,426 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
Director |
|
2019-08-21 |
4 |
S |
$221.56 |
$1,531,862 |
D/D |
(6,914) |
9,903 |
0 |
- |
|
105 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|